Company / Revenue
INSMED Inc Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$606.4M
FY2025
5-year range
$188.5M / $606.4M
FY2021-FY2025
Trend
+66.7%
vs FY2024
Sector context
#61 of 155
Health Care
What the data says
At $606M, INSMED Inc's revenue ranks #61 of 155 in the Health Care sector. Revenue has increased for 8 consecutive years, from $0 in FY2017 to $606M in FY2025.
Based on SEC 10-K filings.
$606M in FY2025 with a 5-year CAGR of +29.8%.
Improved from $305M to $606M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +35.2%
- 5-Year CAGR
- +29.8%
- 10-Year CAGR
- -
Sector benchmark
#61 of 155 in Health CareTop 39% of 155This company $606.4M Sector average $4.5B
▼
-86.4% below sector average
Key checks
Key Insights
- INSMED Inc's revenue has grown for 7 consecutive years.
- 5-year CAGR of +29.8%, indicating consistent growth.
- In FY2025, revenue increased 66.7% year-over-year.
- Ranks #61 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $606.4M | +66.7% |
| FY2024 | $363.7M | +19.2% |
| FY2023 | $305.2M | +24.4% |
| FY2022 | $245.4M | +30.2% |
| FY2021 | $188.5M | +14.6% |
| FY2020 | $164.4M | +20.5% |
| FY2019 | $136.5M | +1287.6% |
| FY2018 | $9.8M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026